ArticleCureus2024
Recurrent Dermatofibrosarcoma Protuberans Over the Face: A Challenging Clinical Problem.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Dermatofibrosarcoma protuberans (DFSP) is a rare, locally aggressive skin malignancy known for its high recurrence rate. It predominantly affects the trunk and extremities but can occasionally present on the face. A 47-year-old man presented with a rapidly progressive, painless swelling on the left side of his face for six months. The swelling, measuring 5x4x2 cm, was well-defined, bosselated, mobile, and firm. MRI revealed a well-defined subcutaneous lesion in the left infraorbital and premaxilla regions, measuring 1.8x3.2x4 cm, with iso to hypointense signals on T1 and hyperintense on T2. Core needle biopsy confirmed DFSP. The patient underwent wide local excision with a pedicled forehead flap. Histopathology confirmed DFSP. The patient received adjuvant radiotherapy (2 Gy daily for five cycles, totaling 60 Gy) and has been disease-free for one year. Facial DFSP is rare and presents unique diagnostic and management challenges. Early diagnosis and comprehensive surgical excision are crucial. Adjuvant therapies and advanced reconstructive techniques significantly improve outcomes. Continued research and documentation of rare DFSP cases are essential to enhance understanding and treatment strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.